Pathological Findings of Post-Viral Olfactory Dysfunction: A Systematic Review

Year 2024, Volume: 7 Issue: 1, 21 - 28, 13.05.2024

Filip Hacksell Amanj Saber

Abstract

The coronavirus disease 2019 pandemic has shed light on the post-viral olfactory dysfunction (PVOD). Post-viral olfactory dysfunction is temporary for most people and usually subsides when the common cold symptoms ameliorate. However, in some patients, this condition can persist for several weeks or months. The exact pathological mechanisms of persistent olfactory loss secondary to upper respiratory tract infection (URTI) is unknown, and there is a lack of effective treatment. An increased understanding of pathology could possibly translate into new therapeutic regimens. The aim of this systematic review is to synthesize primary data regarding histopathological and neuropathological findings in patients with PVOD secondary to URTI. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was followed. Databases PubMed and Web of Science were searched with keywords and mesh terms to identify relevant articles. The quality of included studies was assessed with the Newcastle–Ottawa Scale for observational studies. The search yielded a total of 847 articles, after excluding duplicates and articles that were not relevant. A total of 12 studies were selected. The main findings of this review were: olfactory bulb (OB) volume was decreased in patients with PVOD, there was a negative correlation between OB volume and duration of olfactory loss, both primary and secondary olfactory cortex changes were found in terms of structure and functionality, and the olfactory sensory neurons and nerve bundles were reduced in patients with PVOD. The mechanisms of PVOD are complex. This review found that viral URTI is attributable to structural and
functional changes at multiple locations of the olfactory system.

Keywords

Anosmia , olfactory bulb , olfactory cortex , olfactory dysfunction , post-viral , URTI

References

• Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581.
• Chung MS, Choi WR, Jeong HY, Lee JH, Kim JH. MR imaging-based evaluations of olfactory bulb atrophy in patients with olfactory dysfunction. AJNR Am J Neuroradiol. 2018;39(3):532-537.
• Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life--an updated review. Chem Senses. 2014;39(3):185-194.
• Hura N, Xie DX, Choby GW, et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10(9):1065-1086.
• Passali GC, Passali D, Ciprandi G. Postinfectious olfactory complaints: A follow-up study. Int Arch Otorhinolaryngol. 2022;26(4):e657-e660.
• Branigan B, Tadi P. Physiology, olfactory. StatPearls. St. Petersburg, Florida, United States.2022.
• Purves D, Augustine GJ, Fitzpatrick D, et al., eds.The Olfactory Bulb.Neuroscience. 2nd ed. Sunderland (MA): Sinauer Associates; 2001.
• Lee JC, Nallani R, Cass L, Bhalla V, Chiu AG, Villwock JA. A systematic review of the neuropathologic findings of post-viral olfactory dysfunction: implications and novel insight for the COVID-19 pandemic. Am J Rhinol Allergy. 2021;35(3):323-333.
• Jafek BW, Hartman D, Eller PM, Johnson EW, Strahan RC, Moran DT. Postviral Olfactory Dysfunction. Am J Rhinol Allergy. 1990;4(3):91-100.
• Seiden AM. Postviral olfactory loss. Otolaryngol Clin North Am. 2004;37(6):1159-1166.
• Armien AG, Hu S, Little MR, et al. Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol. 2010;20(4):738-750.
• Chaves AJ, Busquets N, Valle R, et al. Neuropathogenesis of a highly pathogenic avian influenza virus (H7N1) in experimentally infected chickens. Vet Res. 2011;42(1):106.
• Dicpinigaitis PV. Post-viral anosmia (loss of sensation of smell) did not begin with COVID-19!. Lung. 2021;199(3):237-238.
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
• Wells GA, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
• Modesti PA, Reboldi G, Cappuccio FP, et al. Panethnic differences in blood pressure in Europe: A systematic review and meta-analysis. PLoS One. 2016;11(1):e0147601.
• Altundag A, Temirbekov D, Haci C, Yildirim D, Cayonu M. Olfactory cleft width and volume: possible risk factors for postinfectious olfactory dysfunction. Laryngoscope. 2021;131(1):5-9.
• Altundag A, Yıldırım D, Tekcan Sanli DE, et al. Olfactory cleft measurements and COVID-19-related anosmia. Otolaryngol Head Neck Surg. 2021;164(6):1337-1344.
• Kim YK, Hong SL, Yoon EJ, Kim SE, Kim JW. Central presentation of postviral olfactory loss evaluated by positron emission tomography scan: a pilot study. Am J Rhinol Allergy. 2012;26(3):204-208.
• Wolf A, Liesinger L, Spoerk S, et al. Olfactory cleft proteome does not reflect olfactory performance in patients with idiopathic and postinfectious olfactory disorder: a pilot study. Sci Rep. 2018;8(1):17554.
• Yao L, Yi X, Pinto JM, et al. Olfactory cortex and Olfactory bulb volume alterations in patients with post-infectious Olfactory loss. Brain Imaging Behav. 2018;12(5):1355-1362.
• Yildirim D, Altundag A, Tekcan Sanli DE, et al. A new perspective on imaging of olfactory dysfunction: does size matter? Eur J Radiol. 2020;132:109290.
• Yildirim D, Kandemirli SG, Tekcan Sanli DE, Akinci O, Altundag A. A comparative olfactory MRI, DTI and fMRI study of COVID-19 related anosmia and post viral olfactory dysfunction. Acad Radiol. 2022;29(1):31-41.
• Mueller A, Rodewald A, Reden J, Gerber J, von Kummer R, Hummel T. Reduced olfactory bulb volume in post-traumatic and post-infectious olfactory dysfunction. NeuroReport. 2005;16(5):475-478.
• Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. Olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss. Laryngoscope. 2006;116(3):436-439.
• Yamagishi M, Fujiwara M, Nakamura H. Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology. 1994;32(3):113-118.
• Yamagishi M, Nakamura H, Suzuki S, Hasegawa S, Nakano Y. Immunohistochemical examination of olfactory mucosa in patients with olfactory disturbance. Ann Otol Rhinol Laryngol. 1990;99(3 Pt 1):205-210.
• Hong SC, Yoo YS, Kim ES, et al. Development of KVSS Test (Korean Version of Sniffin’ Sticks Test). Korean J Otolaryngol-Head Neck Surg. 1999;42(7):855-860.
• Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. “Sniffin’ sticks”: screening of olfactory performance. Rhinology. 1996;34(4):222-226.
• Takagi SF. A standardized olfactometer in Japan. A review over ten years. Ann N Y Acad Sci. 1987;510:113-118.
• Chen CR, Kachramanoglou C, Li D, Andrews P, Choi D. Anatomy and cellular constituents of the human olfactory mucosa: a review. J Neurol Surg B Skull Base. 2014;75(5):293-300.
• Mori J, Aiba T, Sugiura M, et al. Clinical study of olfactory disturbance. Acta Otolaryngol Suppl. 1998;538:197-201.
• Kalogjera L, Dzepina D. Management of smell dysfunction. Curr Allergy Asthma Rep. 2012.
• Nagayama S, Homma R, Imamura F. Neuronal organization of olfactory bulb circuits. Front Neural Circuits. 2014;8:98.
• Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C. Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-tesla magnetic resonance imaging. Mov Disord. 2012;27(8):1019-1025.
• Yousem DM, Geckle RJ, Bilker WB, Kroger H, Doty RL. Posttraumatic smell loss: relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Acad Radiol. 1999;6(5):264-272.
• Reichert JL, Schöpf V. Olfactory loss and regain: lessons for neuroplasticity. Neuroscientist. 2018;24(1):22-35.
• Patterson A, Hähner A, Kitzler HH, Hummel T. Are small olfactory bulbs a risk for olfactory loss following an upper respiratory tract infection? Eur Arch Otorhinolaryngol. 2015;272(11):3593-3594.
• Ueha R, Mukherjee S, Ueha S, et al. Viral disruption of olfactory progenitors is exacerbated in allergic mice. Int Immunopharmacol. 2014;22(1):242-247.
• Willhite DC, Nguyen KT, Masurkar AV, Greer CA, Shepherd GM, Chen WR. Viral tracing identifies distributed columnar organization in the olfactory bulb. Proc Natl Acad Sci U S A. 2006;103(33):12592-12597.
• Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. J Gen Virol. 1995;76(5):1251-1254.
• Tomlinson AH, Esiri MM. Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci. 1983;60(3):473-484.
• Doty RL, Kamath V. The influences of age on olfaction: a review. Front Psychol. 2014;5:20.